Big E Buys out Rooney

[EyeSore]

I got word that the big E has bought out Rooney , My lab of choice in NE Ohio .

[drk]

Weren't they already partially owned?

If some French guy comes around waving dollars in your face, and you're 60 or older, you're going to think hard about it.

I encourage the indies to hang on. There will be a light at the end of this tunnel.

[David_Garza]

Another one bites the dust!

[Stan Tabor]

Weren't they already partially owned?

If some French guy comes around waving dollars in your face, and you're 60 or older, you're going to think hard about it.

I encourage the indies to hang on. There will be a light at the end of this tunnel.

That light might just be an oncoming train.

[HindSight2020]

That light might just be an oncoming train.

Pulling cars full of green.

[Stan Tabor]

Pulling cars full of green.

Now we're talkin.

[Chris Ryser]

.................and if you are thinking that is the end of it, you are all mistaken.

[jakeller]

So Sad... 87 years in the business...

[coupe]

I understand that Big e owns 402 labs world wide and app 147 in the USA along. Who's left.

[Judy Canty]

Luzerne.

[igirl]

Midwest Labs

[jspayneii]

Icarelabs
Walman
Expert Optics
Cherry Optical - Green Bay
Diversified
QC Optical
Sunburst Optics
RX Optical
FEA Industries

[Chris Ryser]

I understand that Big e owns 402 labs world wide and app 147 in the USA along. Who's left.

About Essilor
The world’s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to improve lives by improving sight. To support this mission, the Company allocates more than €150 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Essilor’s flagship brands are Varilux®, Crizal®, Transitions®, Definity®, Xperio®, OptifogTM, Foster Grant®, Bolon® and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals.
Essilor reported consolidated revenue of over €5 billion in 2013 and employs more than 55,000 people. It distributes its products in some 100 countries with 28 plants, more than 450 prescription laboratories and edging facilities, as well as several research and development centers around the world.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.